REG - ConvaTec Group PLC - Director/PDMR Shareholding
RNS Number : 0698UConvaTec Group PLC26 March 201926 March 2019
ConvaTec Group Plc
("ConvaTec" or "the Company")
Director/PDMR ShareholdingThe Company has been notified of the following transaction by a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").
On 25 March 2019, the Company's Interim Chief Executive Officer and a PDMR, purchased 55,500 Shares at £1.3685 per share. Mr Anderson's resulting shareholding is 204,975 Shares.
The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Rick Anderson
2
Reason for the notification
a)
Position/Status
Interim Chief Executive Officer
b)
Initial notification/Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
ConvaTec Group Plc
b)
LEI
213800LS272L4FIDOH92
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 10p each in ConvaTec Group Plc ("Shares")
GB00BD3VFW73
b)
Nature of the transaction
Purchase of Shares on 25 March 2019
c)
Price(s) and volume(s)
Price(s)
£1.3685
Volume(s)
55,500
d)
Aggregated information
- Aggregated volume
- Price
55,500
£75,951.75
e)
Date of the transaction
25 March 2019
f)
Place of the transaction
London Stock Exchange, Main Market (XLON)
Enquiries
Media
Bobby Leach, VP Group Corporate Affairs, ConvaTec +44 (0)7770 842 226
Alastair Elwen, Finsbury +44 (0)207 251 3801
Analysts and Investors
John Crosse, VP Investor Relations, ConvaTec +44 (0)7500 141 435
Mark Reynolds, Director Investor Relations, ConvaTec +44 (0)7551 036 625
investorrelations@convatec.com
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDDSHLLFSSVDIRFIA
Recent news on ConvaTec
See all newsREG - Convatec Group PLC - Holding(s) in Company
AnnouncementREG - Convatec Group PLC - Posting of Annual Report and Notice of Meeting
AnnouncementREG-Convatec Group PLC Convatec Group PLC: Director/ PDMR Shareholding
AnnouncementREG - ConvaTec Group PLC - Annual Results
AnnouncementREG - ConvaTec Group PLC - Trading Update for ten months to 31 October 2023
Announcement